Gland Pharma Limited has informed the Exchange regarding 'Clarification with respect to Announcement made on 13th April , 2026, regarding Postal Ballot Notice'.
GLAND · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Gland Pharma has clarified its earlier postal ballot notice regarding the reappointment of Ms. Naina Lal Kidwai as an Independent Director for a five-year term from FY 2026-27 to FY 2030-31. The clarification addresses concerns about her remuneration exceeding 50% of total Non-Executive Director pay. The company states it will seek shareholder approval by special resolution each financial year where her individual remuneration crosses this 50% threshold. This is a procedural clarification to ensure compliance with regulatory requirements, not a change in the original proposal.
Minimal impact on shareholders as this is a clarification rather than a new proposal. The stock is unlikely to see any significant movement based on this filing alone.